Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Literature DB >> 33358989

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up^†.

P Bossi¹, A T Chan², L Licitra³, A Trama⁴, E Orlandi⁵, E P Hui², J Halámková⁶, S Mattheis⁷, B Baujat⁸, J Hardillo⁹, L Smeele¹⁰, C van Herpen¹¹, A Castro¹², J-P Machiels¹³.

Abstract

Entities: Disease

Keywords: Clinical Practice Guidelines; diagnosis; follow-up; nasopharyngeal cancer; treatment

Mesh：

Year: 2020 PMID： 33358989 DOI： 10.1016/j.annonc.2020.12.007

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. Pretreatment [¹⁸F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.

Authors: Amina Gihbid; Ghofrane Cherkaoui Salhi; Imane El Alami; Hasnaa Belgadir; Nezha Tawfiq; Karima Bendahou; Mohammed El Mzibri; Rachida Cadi; Naima El Benna; Amal Guensi; Meriem Khyatti
Journal: Ann Nucl Med Date: 2022-07-14 Impact factor: 2.258

2. Moderate Dose Irradiation Induces DNA Damage and Impairments of Barrier and Host Defense in Nasal Epithelial Cells in vitro.

Authors: Yue-Ying Yang; Jing Liu; Yi-Tong Liu; Hsiao-Hui Ong; Qian-Min Chen; Ce-Belle Chen; Mark Thong; Xinni Xu; Sui-Zi Zhou; Qian-Hui Qiu; De-Yun Wang
Journal: J Inflamm Res Date: 2022-06-25

3. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3.

Authors: Hongyu Zhou; Nana Zhang
Journal: Open Med (Wars) Date: 2022-07-12

4. Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

Authors: Wang-Zhong Li; Xing Lv; Dan Hu; Shu-Hui Lv; Guo-Ying Liu; Hu Liang; Yan-Fang Ye; Wen Yang; Han-Xiong Zhang; Tai-Ze Yuan; De-Shen Wang; Nian Lu; Liang-Ru Ke; Wu-Bing Tang; Li-Hua Tong; Zhi-Jie Chen; Ting Liu; Ka-Jia Cao; Hao-Yuan Mo; Ling Guo; Chong Zhao; Ming-Yuan Chen; Qiu-Yan Chen; Pei-Yu Huang; Rui Sun; Fang Qiu; Dong-Hua Luo; Lin Wang; Yi-Jun Hua; Lin-Quan Tang; Chao-Nan Qian; Hai-Qiang Mai; Xiang Guo; Yan-Qun Xiang; Wei-Xiong Xia
Journal: JAMA Oncol Date: 2022-05-01 Impact factor: 33.006

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up^†.

1. Pretreatment [¹⁸F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.

2. Moderate Dose Irradiation Induces DNA Damage and Impairments of Barrier and Host Defense in Nasal Epithelial Cells in vitro.

3. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3.

4. Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

5. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.

6. Case of Nasopharyngeal Carcinoma Presenting With Rare Combination of Multiple Cranial Nerve Palsies.

7. Selectively recommend ¹⁸F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas.

8. Syncope as the Initial Manifestation of Advanced Nasopharyngeal Carcinoma: A Case Report.

9. Biopsy of cervical lymph node does not impact the survival of nasopharyngeal carcinoma.

10. Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma.